Michèle Masquelier
About
In The Last Decade
Michèle Masquelier
33 papers receiving 914 citations
Peers
Comparison fields: 5 of 96
- Molecular Biology 427
- Cancer Research 261
- Oncology 218
- Surgery 161
- Biomaterials 129
Countries citing papers authored by Michèle Masquelier
This map shows the geographic impact of Michèle Masquelier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michèle Masquelier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michèle Masquelier more than expected).
Fields of papers citing papers by Michèle Masquelier
This network shows the impact of papers produced by Michèle Masquelier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michèle Masquelier. The network helps show where Michèle Masquelier may publish in the future.
Co-authorship network of co-authors of Michèle Masquelier
This figure shows the co-authorship network connecting the top 25 collaborators of Michèle Masquelier. A scholar is included among the top collaborators of Michèle Masquelier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michèle Masquelier. Michèle Masquelier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 26 | |
| 2 | 4 | |
| 3 | 14 | |
| 4 | 16 | |
| 5 | 9 | |
| 6 | 8 | |
| 7 | 13 | |
| 8 | 20 | |
| 9 | 19 | |
| 10 | 18 | |
| 11 | 33 | |
| 12 | 46 | |
| 13 | 12 | |
| 14 | 21 | |
| 15 | 15 | |
| 16 | 62 | |
| 17 | On the paradoxically concentration-dependent metabolism of 6-mercaptopurine in WEHI-3b murine leukemia cells. | 20 |
| 18 | Low-density lipoprotein as a carrier of antitumoral drugs: in vivo fate of drug-human low-density lipoprotein complexes in mice. | 78 |
| 19 | Targeting of Daunorubicin By Covalent and Reversible Linkage To Carrier Proteins - Lysosomal Hydrolysis and Anti-tumoral Activity of Conjugates Prepared With Peptidic Spacer Arms | 6 |
| 20 | Binding and Uptake of Galactosylated Serum-albumin By Different Human Cultured Hepatoma | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.